1.
|
Phase: Phase IV
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ML18527, NCT00121836
|
|
2.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: EORTC-10001, EORTC-16001O, IDBBC-EORTC-10001, NCT00049660
|
|
3.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: Over 18
Sponsor: Other
Protocol IDs: MRC-LU23, EU-20535, EU-INCH-20535, EudraCT-2004-004438-15, NCT00253591
|
|
4.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CAN-NCIC-BR10, CLB-9795, E-JBR10, SWOG-JBR10, GW-565/040, NCI-V94-0492, NCT00002583, BR10, JBR10
|
|
5.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 75
Sponsor:
Protocol IDs: DAN-DBCG-94-03, EU-95008
|
|
6.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: SWOG-9509
|
|
7.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: MSKCC-95088, RP-56976-TAX-320, NCI-V96-0830
|
|
8.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 75
Sponsor: Other
Protocol IDs: FRE-IALT, EU-96010, NCT00002823
|
|
9.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: under 65
Sponsor:
Protocol IDs: FRE-FNCLCC-GFEA-09, EU-96015, FRE-GFEA-09
|
|
10.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: Any age
Sponsor: Other
Protocol IDs: MRC-LU22, EORTC-08012, EU-97016, ISRCTN25582437, NCT00003159
|
|
11.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: Adult
Sponsor:
Protocol IDs: LLCG-BLT, MRC-BLT, EU-98003, NCT00003240
|
|
12.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 70 and over
Sponsor:
Protocol IDs: ITA-MILES, ITA-GOCSI-MILES, EU-98019, NCT00003447
|
|
13.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: RP-56976-TAX-326, RP-56976-V-326
|
|
14.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: Under 70
Sponsor: Other
Protocol IDs: ITA-GEMVIN, CAN-NCIC-BR14, EU-99016, NCT00004100, BR14
|
|
15.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCCAM, NCI
Protocol IDs: MDA-ID-99303, NCCAM, NCI-T99-0046, NCT00005838, RTOG-0270
|
|
16.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SANOFI-EFC3675, NCT00017459
|
|
17.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: Any age
Sponsor: Pharmaceutical / Industry
Protocol IDs: LIGAND-L1069-49
|
|
18.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: BW-P70-34972-02, NCI-V91-0069
|
|
19.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: BW-P70-34972-01, NCI-V91-0068
|
|
20.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 75
Sponsor:
Protocol IDs: CAN-NCIC-MA8, NCI-V92-0010, MA8
|
|
21.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: over 18
Sponsor: NCI
Protocol IDs: SWOG-9308
|
|
22.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CTI-PGT304, NCT00054197
|
|
23.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: GOG-0204, NCT00064077
|
|
24.
|
Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: BTS-MRC-MS01, ISRCTN54469112, EU-20349, NCT00075699
|
|
25.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: JMTO-LC00-03, NCT00079287
|
